Global Central Nervous System Disorders Therapeutics Market 2016-2020

Published: September 2016
No. of Pages: 147
Single User License: US $ 2500
Corporate User License: US $ 4000

CNS disorders can affect either the brain or spinal cord, or both. CNS disorders are also called as neurological and psychiatric disorders. The major causes of CNS disorders are infections, trauma, degeneration, structural defects, tumors, autoimmune disorders, and stroke. A headache, muscle weakness, memory loss, impaired mental ability, and lack of coordination are few of the symptoms of CNS disorders.

The analysts forecast global central nervous system (CNS) disorders therapeutics market to grow at a CAGR of 3.38% during the period 2016-2020.

Covered in this report

This report covers the present scenario and the growth prospects of the global central nervous system (CNS) disorders therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-labeled drugs used for the treatment of various CNS disorders including bipolar disorders, depression, epilepsy, PD, AD, Huntington's disease (HD), multiple sclerosis (MS), schizophrenia, attention-deficit hyperactivity disorder (ADHD), migraine, and anxiety.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Central Nervous System (CNS) Disorders Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Janssen Pharmaceuticals
  • Novartis

Other prominent vendors

  • AB Science
  • AbbVie
  • Abital Pharma
  • Acorda Therapeutics
  • Active Biotech
  • Adamas Pharmaceuticals
  • Addex Therapeutics
  • Akorn
  • Alcobra
  • Alexza Pharmaceuticals
  • Alkermes
  • Amarantus
  • Aprecia Pharmaceuticals
  • Archer Pharmaceuticals
  • Astellas
  • AstraZeneca
  • Aurobindo Pharma
  • Auspex Pharmaceuticals
  • Avanir Pharmaceuticals
  • Biscayne Pharmaceuticals
  • Boehringer Ingelheim
  • Cerecor
  • Concordia
  • Convergence Pharmaceuticals
  • Curemark
  • CURx Pharmaceuticals
  • Dainippon Sumitomo Pharma
  • Dart NeuroScience
  • Delpor
  • Desitin Arzneimittel
  • D-Pharm
  • Edgemont Pharmaceuticals
  • Endo International
  • E-Therapeutics
  • Euthymics
  • Evotec
  • F. Hoffmann-La Roche
  • Fabre-Kramer Pharmaceuticals
  • Forum Pharmaceuticals
  • Gedeon Richter
  • Glenmark
  • Grupo Ferrer Internacional
  • GW Pharmaceuticals
  • H. Lundbeck
  • Hisamitsu
  • Impax
  • Insero Health
  • INSYS Therapeutics
  • Intellipharmaceutics
  • Intra-Cellular Therapies
  • Ipsen
  • Kyowa Hakko Kirin
  • Ligand Pharmaceuticals
  • Lupin
  • MarcoPolo Pharmaceuticals
  • Marinus Pharmaceuticals
  • Meda AB
  • Merck
  • Mitsubishi Tanabe
  • MSI Methylation Sciences
  • Mylan
  • Naurex
  • Neuralstem
  • Neurelis
  • Neurovance
  • Nobelpharma
  • Noven Pharmaceuticals
  • Omeros
  • Opexa
  • Opko Health
  • Orion
  • Ophelia Pharmaceutical
  • Otsuka Pharmaceuticals
  • Palobiofarma
  • Par Pharmaceuticals
  • Pierre Fabre
  • Prana Biotechnology
  • Raptor Pharmaceutical
  • Reviva Pharmaceuticals
  • SAGE Therapeutics
  • Sanofi
  • SciFlour
  • Sedor Pharmaceuticals
  • Shire
  • Siena Biotech
  • SK Biopharmaceuticals
  • SOM Biotech
  • Somerset Pharmaceuticals
  • STADA Arzneimittel
  • Sun Pharmaceuticalc
  • Sunovion Pharmaceuticals
  • Supernus Pharmaceuticals
  • Suven
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals
  • Torrent Pharmaceuticals
  • Tris Pharma
  • Turing Pharmaceuticals
  • UCB
  • US WorldMeds
  • Valeant Pharmaceuticals
  • Zinfandel Pharmaceuticals
  • Zogenix

Market driver

  • New DMD approvals for AD, PD, and MS
  • For a full, detailed list, view our report

Market challenge

  • High failure rates of late-stage products in clinical trials
  • For a full, detailed list, view our report

Market trend

  • Increased uptake of new-generation drugs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Published By: Technavio
Product Code: Infiniti Research Limited13268

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:


  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: